While Foundayo’s insulin-matching potential in type 2 diabetes had been established in a topline readout earlier this year, ...

Taiho Pharmaceuticals, together with U.S.-based subsidiary Taiho Oncology, has inched closer to approval of another oral ...

Real Chemistry has created an artificial intelligence-enabled platform to improve a manual, fragmented stage of the ...

The start-up, which deploys unmanned, reusable rockets into Earth’s low-orbit, secured another $251 million in a series D ...

Come year’s end, more than 100 Novo employees reporting to the Danish drugmaker’s outpost in Plainsboro, New Jersey, will be ...

CSL Seqirus, a unit of the Australian biopharma CSL, is touting a surplus of its influenza vaccines in the U.S. ahead of the ...

The European Commission has revoked the EU marketing authorization for Hansoh Pharma’s lung cancer drug Aumseqa (aumolertinib ...

Just months after trimming jobs in New Jersey following an acquisition, BioMarin is laying off 117 employees in California as ...

Bookended by its first commercial-scale manufacturing of the radioisotope actinium-225 in January and an expected ...

In Milan this week, Novo and Eli Lilly took the stage at the European Association for the Study of Diabetes 2026 meeting with ...

Following news of a planned CEO departure for the United States’ top drug industry lobbying group, the Pharmaceutical ...

Alnylam Pharmaceuticals has teamed up with Pete Shaw, making the retired professional football player the star of its “Play ...